Related Articles

News
STAT+: Third Rock Ventures plots next chapter after raising $1.1 billion fund
June 15, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Third Rock Ventures plots next chapter after raising $1.1 billion fund
Third Rock Venture partners Abbie Celniker and Reid Huber spoke with STAT about their plans for investing their sixth and largest fund. The lion’s share of the $1.1 billion they… […]

News
STAT+: Pharmalittle: Where is PhRMA in the abortion pill debate? Most late-stage MS drug trials were never published
April 12, 2023
San Francisco Biotechnology Network News
News, Syndication
Comments Off on STAT+: Pharmalittle: Where is PhRMA in the abortion pill debate? Most late-stage MS drug trials were never published
Stanford’s president took responsibility for the decision not to correct or retract a paper at the heart of a research misconduct investigation. […]

News
STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case
March 31, 2023
San Francisco Biotechnology Network News
News, Syndication
Comments Off on STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case
A federal judge reversed a major Obamacare provision requiring plans to cover preventive care ranging from disease screenings to pregnancy care. […]